Stefan Leucht
Department of Psychiatry and Psychotherapy
Technische Universität München
Klinikum rechts der Isar
München
Germany
Name/email consistency: high
- Evidence-based pharmacotherapy of schizophrenia. Leucht, S., Heres, S., Kissling, W., Davis, J.M. Int. J. Neuropsychopharmacol. (2011)
- A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Leucht, S., Komossa, K., Rummel-Kluge, C., Corves, C., Hunger, H., Schmid, F., Asenjo Lobos, C., Schwarz, S., Davis, J.M. Am. J. Psychiatry (2009)
- Second-generation antipsychotics for schizophrenia: can we resolve the conflict?. Leucht, S., Kissling, W., Davis, J.M. Psychol. Med (2009)
- Lithium for schizophrenia. Leucht, S., Kissling, W., McGrath, J. Cochrane. Database. Syst. Rev (2007)
- Carbamazepine for schizophrenia. Leucht, S., Kissling, W., McGrath, J., White, P. Cochrane. Database. Syst. Rev (2007)
- The concepts of remission and recovery in schizophrenia. Leucht, S., Lasser, R. Pharmacopsychiatry (2006)
- Perazine for schizophrenia. Leucht, S., Hartung, B. Cochrane. Database. Syst. Rev (2006)
- Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. Leucht, S., Heres, S. J. Clin. Psychiatry (2006)
- Benperidol for schizophrenia. Leucht, S., Hartung, B. Cochrane. Database. Syst. Rev (2005)
- Clinical implications of Brief Psychiatric Rating Scale scores. Leucht, S., Kane, J.M., Kissling, W., Hamann, J., Etschel, E., Engel, R. Br. J. Psychiatry (2005)
- Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials. Leucht, S. Int. J. Neuropsychopharmacol. (2004)
- Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Leucht, S., Barnes, T.R., Kissling, W., Engel, R.R., Correll, C., Kane, J.M. Am. J. Psychiatry (2003)
- Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials. Leucht, S., Pitschel-Walz, G., Engel, R.R., Kissling, W. Am. J. Psychiatry (2002)
- Perazine for schizophrenia. Leucht, S., Hartung, B. Cochrane. Database. Syst. Rev (2002)
- Benperidol for schizophrenia. Leucht, S., Hartung, B. Cochrane. Database. Syst. Rev (2002)
- Carbamazepine augmentation for schizophrenia: how good is the evidence?. Leucht, S., McGrath, J., White, P., Kissling, W. J. Clin. Psychiatry (2002)
- Carbamazepine for schizophrenia and schizoaffective psychoses. Leucht, S., McGrath, J., White, P., Kissling, W. Cochrane. Database. Syst. Rev (2002)
- Doxepin plasma concentrations: is there really a therapeutic range?. Leucht, S., Steimer, W., Kreuz, S., Abraham, D., Orsulak, P.J., Kissling, W. J. Clin. Psychopharmacol (2001)
- Carbamazepine for schizophrenia and schizoaffective psychoses. Leucht, S., McGrath, J., White, P., Kissling, W. Cochrane. Database. Syst. Rev (2000)
- Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Leucht, S., Pitschel-Walz, G., Abraham, D., Kissling, W. Schizophr. Res. (1999)